Market Research Logo

Global Pain Management Drugs Market 2018-2022

Global Pain Management Drugs Market 2018-2022

About this market

Numerous diseases and conditions are associated with pain, including arthritis, peripheral neurology, fibromyalgia and shingles. Low back pain is a common health problem in the workplace and most people are expected to experience symptoms of low back pain during their working life. Such an increase in the prevalence of chronic pain conditions will drive the global pain management drugs market during our forecast period. Technavio’s analysts have predicted that the pain management drugs market will register a CAGR of nearly 4% by 2022.

Market Overview

Strong pipeline and recently approved pain management drugs

Most of the therapeutics that are in the last stage of development are expected to get marketing approval during our forecast period. Apart from the strong pipeline of late- stage molecules, recent approvals are expected to drive the global pain management drugs market.

High influx of generic drugs

Patent cliff and high prices of branded drugs result in a high influx of genetic drugs. The major reasons behind high drug prices are drug regulatory policies or industrial pricing strategies, and policy measures.

For the detailed list of factors that will drive and challenge the growth of the pain management drugs market during the 2018-2022, view our report.

Competitive Landscape

The pain management drugs market appears to be fragmented and with the presence of several companies including. The vendors in the market have strong R&D pipelines for new investigational pain management medicines. The robust pipelines for pain management drugs will likely propel the market’s growth. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global CNS therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Pain management pipeline
      • Table Pain management pipeline 2017-2018
  • Market sizing
    • Market definition
      • Table Market definition – Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global pain management drugs market – Market size and forecast 2017-2022 ($ mn)
      • Table Global pain management drugs market – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition – Five forces 2017
  • Market segmentation by pain types
    • Segmentation by pain types
    • Nociceptive pain
    • Neuropathic pain
    • Psychogenic pain
  • Market segmentation by product
    • Segmentation by product
      • Table Global pain management drugs market by product – Market share 2017-2022 (%)
    • Comparison by product
      • Table Comparison by product
    • Opioids – Market size and forecast 2017-2022
      • Table Opioids – Market size and forecast 2017-2022 ($ mn)
      • Table Opioids – Year-over-year growth 2018-2022 (%)
    • NSAIDs – Market size and forecast 2017-2022
      • Table NSAIDs – Market size and forecast 2017-2022 ($ mn)
      • Table NSAIDs – Year-over-year growth 2018-2022 (%)
    • Others – Market size and forecast 2017-2022
      • Table Others – Market size and forecast 2017-2022 ($ mn)
      • Table Selected current other types of drugs for neuropathic pain
      • Table Others – Year-over-year growth 2018-2022 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global pain management drugs market by geography – Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ mn)
      • Table Americas – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ mn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Increasing geriatric population in Europe
      • Table Percentage of older Americans experiencing chronic pain conditions 2014
      • Table Some of the recently approved drugs by the US FDA for pain management
    • Market challenges
  • Market trends
    • Increase in prevalence of pain associated with chronic diseases
    • Significant increase in the use of opioids for pain management
    • Novel drug delivery systems and novel targets for pain management
      • Table Some of the novel abuse-deterrent opioids and monoclonal antibodies
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Endo Pharmaceuticals
      • Table Endo Pharmaceuticals: An overview
      • Table Endo Pharmaceuticals – Business segments
      • Table Endo Pharmaceuticals – Organizational developments
      • Table Endo Pharmaceuticals – Segment focus
      • Table Endo Pharmaceuticals – Key offerings
    • GlaxoSmithKline
      • Table GlaxoSmithKline: An overview
      • Table GlaxoSmithKline – Business segments
      • Table GlaxoSmithKline – Organizational developments
      • Table GlaxoSmithKline – Geographic focus
      • Table GlaxoSmithKline – Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson: An overview
      • Table Johnson & Johnson – Business segments
      • Table Johnson & Johnson – Organizational developments
      • Table Johnson & Johnson – Geographic focus
      • Table Johnson & Johnson – Segment focus
      • Table Johnson & Johnson – Key offerings
    • Pfizer
      • Table Pfizer: An overview
      • Table Pfizer – Business segments
      • Table Pfizer – Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer – Segment focus
      • Table Pfizer – Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook